We are live on ! Find out more
MATN

Mateon Therapeutics, Inc.
MATN

Delisted

MATN was delisted on the 7th of December, 2016.

Back to rankings

1 hedge funds and large institutions have $6K invested in Mateon Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$6K

Top Sellers

No sellers this quarter

MATN Hedge Fund Activity: Q3 2020 in Review

1 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Mateon Therapeutics, Inc. (MATN) for Q3 2020, worth a combined $6K.

Buyers outnumbered sellers: 1 fund opened new MATN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was IFP Advisors, opening a new position worth an estimated $6K.

  • 1 institutional investor held Mateon Therapeutics, Inc. (MATN) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $6K of Mateon Therapeutics, Inc. stock for Q3 2020.
  • 1 fund opened new Mateon Therapeutics, Inc. positions in Q3 2020 and 0 closed out, a net change of +1 holder.
  • The largest Mateon Therapeutics, Inc. buyer in Q3 2020 was IFP Advisors, an estimated $6K added.

Based on aggregated 13F filings for Q3 2020.